Recruiting at 1 site No phase Bipolar Disorder

Clinical trial for Bipolar Disorder

Official title Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder

ClinicalTrials.gov ID: NCT05153382

What this study is testing

What it's testing
This study is testing whether a specific talk therapy helps young people. It also looks at what makes the therapy work best.
Who it's for
You may be able to join if you are a young person with or at risk for bipolar disorder.
What's involved
You would take part in group skills training and one-on-one therapy sessions. You would learn skills to manage emotions and handle stress.
Time commitment
The study lasts for one year and includes regular therapy visits.
  • Time commitment: about 1 year

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 to 23

You may be able to join if

  • 1) English-speaking; 2) Age 13 years, 0 months to 23 years, 11 months

You likely can't join if

  • 1) Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder by the K-SADS-PL (\< 20...

The study team makes the final eligibility decision.

Where it is enrolling

  • Toronto, Ontario, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 1 year per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years to 23 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.